3
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

3
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Doxorubicin Injection Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-8D8014
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Doxorubicin Injection Market Insights and Forecast to 2028
BUY CHAPTERS

Global Doxorubicin Injection Market Research Report 2025

Code: QYRE-Auto-8D8014
Report
July 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Doxorubicin Injection Market

The global market for Doxorubicin Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Doxorubicin is a chemotherapy medication that treats several types of cancer like leukemia, lymphoma, neuroblastoma and sarcoma.
North American market for Doxorubicin Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Doxorubicin Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Doxorubicin Injection include Hikma, Pfizer, Fresenius Kabi, Mylan, Sagent, Teva, AdvaCare Pharma, TAJ Pharma, Getwell Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Doxorubicin Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Doxorubicin Injection.
The Doxorubicin Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Doxorubicin Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Doxorubicin Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Doxorubicin Injection Market Report

Report Metric Details
Report Name Doxorubicin Injection Market
Segment by Type
  • 5ml/vial
  • 10ml/vial
  • 50ml/vial
Segment by Application
  • Hospital
  • Clinics
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Hikma, Pfizer, Fresenius Kabi, Mylan, Sagent, Teva, AdvaCare Pharma, TAJ Pharma, Getwell Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Doxorubicin Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Doxorubicin Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Doxorubicin Injection Market report?

Ans: The main players in the Doxorubicin Injection Market are Hikma, Pfizer, Fresenius Kabi, Mylan, Sagent, Teva, AdvaCare Pharma, TAJ Pharma, Getwell Pharma

What are the Application segmentation covered in the Doxorubicin Injection Market report?

Ans: The Applications covered in the Doxorubicin Injection Market report are Hospital, Clinics, Others

What are the Type segmentation covered in the Doxorubicin Injection Market report?

Ans: The Types covered in the Doxorubicin Injection Market report are 5ml/vial, 10ml/vial, 50ml/vial

1 Doxorubicin Injection Market Overview
1.1 Product Definition
1.2 Doxorubicin Injection by Type
1.2.1 Global Doxorubicin Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 5ml/vial
1.2.3 10ml/vial
1.2.4 50ml/vial
1.3 Doxorubicin Injection by Application
1.3.1 Global Doxorubicin Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Others
1.4 Global Doxorubicin Injection Market Size Estimates and Forecasts
1.4.1 Global Doxorubicin Injection Revenue 2020-2031
1.4.2 Global Doxorubicin Injection Sales 2020-2031
1.4.3 Global Doxorubicin Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Doxorubicin Injection Market Competition by Manufacturers
2.1 Global Doxorubicin Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Doxorubicin Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Doxorubicin Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Doxorubicin Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Doxorubicin Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Doxorubicin Injection, Product Type & Application
2.7 Global Key Manufacturers of Doxorubicin Injection, Date of Enter into This Industry
2.8 Global Doxorubicin Injection Market Competitive Situation and Trends
2.8.1 Global Doxorubicin Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Doxorubicin Injection Players Market Share by Revenue
2.8.3 Global Doxorubicin Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Doxorubicin Injection Market Scenario by Region
3.1 Global Doxorubicin Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Doxorubicin Injection Sales by Region: 2020-2031
3.2.1 Global Doxorubicin Injection Sales by Region: 2020-2025
3.2.2 Global Doxorubicin Injection Sales by Region: 2026-2031
3.3 Global Doxorubicin Injection Revenue by Region: 2020-2031
3.3.1 Global Doxorubicin Injection Revenue by Region: 2020-2025
3.3.2 Global Doxorubicin Injection Revenue by Region: 2026-2031
3.4 North America Doxorubicin Injection Market Facts & Figures by Country
3.4.1 North America Doxorubicin Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Doxorubicin Injection Sales by Country (2020-2031)
3.4.3 North America Doxorubicin Injection Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Doxorubicin Injection Market Facts & Figures by Country
3.5.1 Europe Doxorubicin Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Doxorubicin Injection Sales by Country (2020-2031)
3.5.3 Europe Doxorubicin Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Doxorubicin Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Doxorubicin Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Doxorubicin Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Doxorubicin Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Doxorubicin Injection Market Facts & Figures by Country
3.7.1 Latin America Doxorubicin Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Doxorubicin Injection Sales by Country (2020-2031)
3.7.3 Latin America Doxorubicin Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Doxorubicin Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Doxorubicin Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Doxorubicin Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Doxorubicin Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Doxorubicin Injection Sales by Type (2020-2031)
4.1.1 Global Doxorubicin Injection Sales by Type (2020-2025)
4.1.2 Global Doxorubicin Injection Sales by Type (2026-2031)
4.1.3 Global Doxorubicin Injection Sales Market Share by Type (2020-2031)
4.2 Global Doxorubicin Injection Revenue by Type (2020-2031)
4.2.1 Global Doxorubicin Injection Revenue by Type (2020-2025)
4.2.2 Global Doxorubicin Injection Revenue by Type (2026-2031)
4.2.3 Global Doxorubicin Injection Revenue Market Share by Type (2020-2031)
4.3 Global Doxorubicin Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Doxorubicin Injection Sales by Application (2020-2031)
5.1.1 Global Doxorubicin Injection Sales by Application (2020-2025)
5.1.2 Global Doxorubicin Injection Sales by Application (2026-2031)
5.1.3 Global Doxorubicin Injection Sales Market Share by Application (2020-2031)
5.2 Global Doxorubicin Injection Revenue by Application (2020-2031)
5.2.1 Global Doxorubicin Injection Revenue by Application (2020-2025)
5.2.2 Global Doxorubicin Injection Revenue by Application (2026-2031)
5.2.3 Global Doxorubicin Injection Revenue Market Share by Application (2020-2031)
5.3 Global Doxorubicin Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Hikma
6.1.1 Hikma Company Information
6.1.2 Hikma Description and Business Overview
6.1.3 Hikma Doxorubicin Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Hikma Doxorubicin Injection Product Portfolio
6.1.5 Hikma Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Doxorubicin Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Doxorubicin Injection Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Fresenius Kabi
6.3.1 Fresenius Kabi Company Information
6.3.2 Fresenius Kabi Description and Business Overview
6.3.3 Fresenius Kabi Doxorubicin Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Fresenius Kabi Doxorubicin Injection Product Portfolio
6.3.5 Fresenius Kabi Recent Developments/Updates
6.4 Mylan
6.4.1 Mylan Company Information
6.4.2 Mylan Description and Business Overview
6.4.3 Mylan Doxorubicin Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Mylan Doxorubicin Injection Product Portfolio
6.4.5 Mylan Recent Developments/Updates
6.5 Sagent
6.5.1 Sagent Company Information
6.5.2 Sagent Description and Business Overview
6.5.3 Sagent Doxorubicin Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sagent Doxorubicin Injection Product Portfolio
6.5.5 Sagent Recent Developments/Updates
6.6 Teva
6.6.1 Teva Company Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Doxorubicin Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Teva Doxorubicin Injection Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 AdvaCare Pharma
6.7.1 AdvaCare Pharma Company Information
6.7.2 AdvaCare Pharma Description and Business Overview
6.7.3 AdvaCare Pharma Doxorubicin Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 AdvaCare Pharma Doxorubicin Injection Product Portfolio
6.7.5 AdvaCare Pharma Recent Developments/Updates
6.8 TAJ Pharma
6.8.1 TAJ Pharma Company Information
6.8.2 TAJ Pharma Description and Business Overview
6.8.3 TAJ Pharma Doxorubicin Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 TAJ Pharma Doxorubicin Injection Product Portfolio
6.8.5 TAJ Pharma Recent Developments/Updates
6.9 Getwell Pharma
6.9.1 Getwell Pharma Company Information
6.9.2 Getwell Pharma Description and Business Overview
6.9.3 Getwell Pharma Doxorubicin Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Getwell Pharma Doxorubicin Injection Product Portfolio
6.9.5 Getwell Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Doxorubicin Injection Industry Chain Analysis
7.2 Doxorubicin Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Doxorubicin Injection Production Mode & Process Analysis
7.4 Doxorubicin Injection Sales and Marketing
7.4.1 Doxorubicin Injection Sales Channels
7.4.2 Doxorubicin Injection Distributors
7.5 Doxorubicin Injection Customer Analysis
8 Doxorubicin Injection Market Dynamics
8.1 Doxorubicin Injection Industry Trends
8.2 Doxorubicin Injection Market Drivers
8.3 Doxorubicin Injection Market Challenges
8.4 Doxorubicin Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Doxorubicin Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Doxorubicin Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Doxorubicin Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Doxorubicin Injection Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Doxorubicin Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Doxorubicin Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Doxorubicin Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Doxorubicin Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Doxorubicin Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Doxorubicin Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Doxorubicin Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Doxorubicin Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Doxorubicin Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Doxorubicin Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Doxorubicin Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Doxorubicin Injection Sales by Region (2020-2025) & (K Units)
 Table 18. Global Doxorubicin Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Doxorubicin Injection Sales by Region (2026-2031) & (K Units)
 Table 20. Global Doxorubicin Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Doxorubicin Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Doxorubicin Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Doxorubicin Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Doxorubicin Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Doxorubicin Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Doxorubicin Injection Sales by Country (2020-2025) & (K Units)
 Table 27. North America Doxorubicin Injection Sales by Country (2026-2031) & (K Units)
 Table 28. North America Doxorubicin Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Doxorubicin Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Doxorubicin Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Doxorubicin Injection Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Doxorubicin Injection Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Doxorubicin Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Doxorubicin Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Doxorubicin Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Doxorubicin Injection Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Doxorubicin Injection Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Doxorubicin Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Doxorubicin Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Doxorubicin Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Doxorubicin Injection Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Doxorubicin Injection Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Doxorubicin Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Doxorubicin Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Doxorubicin Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Doxorubicin Injection Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Doxorubicin Injection Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Doxorubicin Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Doxorubicin Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Doxorubicin Injection Sales (K Units) by Type (2020-2025)
 Table 51. Global Doxorubicin Injection Sales (K Units) by Type (2026-2031)
 Table 52. Global Doxorubicin Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Doxorubicin Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Doxorubicin Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Doxorubicin Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Doxorubicin Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Doxorubicin Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Doxorubicin Injection Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Doxorubicin Injection Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Doxorubicin Injection Sales (K Units) by Application (2020-2025)
 Table 61. Global Doxorubicin Injection Sales (K Units) by Application (2026-2031)
 Table 62. Global Doxorubicin Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Doxorubicin Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Doxorubicin Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Doxorubicin Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Doxorubicin Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Doxorubicin Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Doxorubicin Injection Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Doxorubicin Injection Price (US$/Unit) by Application (2026-2031)
 Table 70. Hikma Company Information
 Table 71. Hikma Description and Business Overview
 Table 72. Hikma Doxorubicin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Hikma Doxorubicin Injection Product
 Table 74. Hikma Recent Developments/Updates
 Table 75. Pfizer Company Information
 Table 76. Pfizer Description and Business Overview
 Table 77. Pfizer Doxorubicin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Pfizer Doxorubicin Injection Product
 Table 79. Pfizer Recent Developments/Updates
 Table 80. Fresenius Kabi Company Information
 Table 81. Fresenius Kabi Description and Business Overview
 Table 82. Fresenius Kabi Doxorubicin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Fresenius Kabi Doxorubicin Injection Product
 Table 84. Fresenius Kabi Recent Developments/Updates
 Table 85. Mylan Company Information
 Table 86. Mylan Description and Business Overview
 Table 87. Mylan Doxorubicin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Mylan Doxorubicin Injection Product
 Table 89. Mylan Recent Developments/Updates
 Table 90. Sagent Company Information
 Table 91. Sagent Description and Business Overview
 Table 92. Sagent Doxorubicin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Sagent Doxorubicin Injection Product
 Table 94. Sagent Recent Developments/Updates
 Table 95. Teva Company Information
 Table 96. Teva Description and Business Overview
 Table 97. Teva Doxorubicin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Teva Doxorubicin Injection Product
 Table 99. Teva Recent Developments/Updates
 Table 100. AdvaCare Pharma Company Information
 Table 101. AdvaCare Pharma Description and Business Overview
 Table 102. AdvaCare Pharma Doxorubicin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. AdvaCare Pharma Doxorubicin Injection Product
 Table 104. AdvaCare Pharma Recent Developments/Updates
 Table 105. TAJ Pharma Company Information
 Table 106. TAJ Pharma Description and Business Overview
 Table 107. TAJ Pharma Doxorubicin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. TAJ Pharma Doxorubicin Injection Product
 Table 109. TAJ Pharma Recent Developments/Updates
 Table 110. Getwell Pharma Company Information
 Table 111. Getwell Pharma Description and Business Overview
 Table 112. Getwell Pharma Doxorubicin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Getwell Pharma Doxorubicin Injection Product
 Table 114. Getwell Pharma Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Doxorubicin Injection Distributors List
 Table 118. Doxorubicin Injection Customers List
 Table 119. Doxorubicin Injection Market Trends
 Table 120. Doxorubicin Injection Market Drivers
 Table 121. Doxorubicin Injection Market Challenges
 Table 122. Doxorubicin Injection Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Doxorubicin Injection
 Figure 2. Global Doxorubicin Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Doxorubicin Injection Market Share by Type: 2024 & 2031
 Figure 4. 5ml/vial Product Picture
 Figure 5. 10ml/vial Product Picture
 Figure 6. 50ml/vial Product Picture
 Figure 7. Global Doxorubicin Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Doxorubicin Injection Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Clinics
 Figure 11. Others
 Figure 12. Global Doxorubicin Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Doxorubicin Injection Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Doxorubicin Injection Sales (2020-2031) & (K Units)
 Figure 15. Global Doxorubicin Injection Average Price (US$/Unit) & (2020-2031)
 Figure 16. Doxorubicin Injection Report Years Considered
 Figure 17. Doxorubicin Injection Sales Share by Manufacturers in 2024
 Figure 18. Global Doxorubicin Injection Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Doxorubicin Injection Players: Market Share by Revenue in Doxorubicin Injection in 2024
 Figure 20. Doxorubicin Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Doxorubicin Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Doxorubicin Injection Sales Market Share by Country (2020-2031)
 Figure 23. North America Doxorubicin Injection Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Doxorubicin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Doxorubicin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Doxorubicin Injection Sales Market Share by Country (2020-2031)
 Figure 27. Europe Doxorubicin Injection Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Doxorubicin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Doxorubicin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Doxorubicin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Doxorubicin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Doxorubicin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Doxorubicin Injection Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Doxorubicin Injection Revenue Market Share by Region (2020-2031)
 Figure 35. China Doxorubicin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Doxorubicin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Doxorubicin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Doxorubicin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Doxorubicin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Doxorubicin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Doxorubicin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Doxorubicin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Doxorubicin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Doxorubicin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Doxorubicin Injection Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Doxorubicin Injection Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Doxorubicin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Doxorubicin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Doxorubicin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Doxorubicin Injection Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Doxorubicin Injection Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Doxorubicin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Doxorubicin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Doxorubicin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Doxorubicin Injection by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Doxorubicin Injection by Type (2020-2031)
 Figure 57. Global Doxorubicin Injection Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Doxorubicin Injection by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Doxorubicin Injection by Application (2020-2031)
 Figure 60. Global Doxorubicin Injection Price (US$/Unit) by Application (2020-2031)
 Figure 61. Doxorubicin Injection Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure